" /> 213Bi-cDTPA-9.2.27 monoclonal antibody - CISMeF





Preferred Label : 213Bi-cDTPA-9.2.27 monoclonal antibody;

MeSH note : in Phase 1 dose escalation trials for treating metastatic melanoma;

Is substance : O;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.